Hadi Kalantar
Hadi Kalantar publishes mostly in Pharmacology, Pathology and Forensic Medicine and Molecular Biology, on topics such as Drug-Induced Hepatotoxicity and Protection, Chemotherapy-induced organ toxicity mitigation and Acute Lymphoblastic Leukemia research.
- World rank
- #1,403,021 of 7,710,434 ranked researchers
- Rank in Iran
- #7,605 of 71,317
- Works
- 49
- Citations
- 880
- Citations per work
- 18.0
What does Hadi Kalantar research?
Hadi Kalantar's work is mostly in Medicine (20%), Pharmacology, Toxicology and Pharmaceutics (13%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2654.0%
- Life Sciences1020.8%
- Health Sciences1020.2%
- Medicine1020.2%
- Physical Sciences25.0%
- 1Pharmacology13% of their works
- 2Pathology and Forensic Medicine9% of their works
- 3Molecular Biology8% of their works
- 4Pharmacology6% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Health, Toxicology and Mutagenesis5% of their works
Research topics
- Drug-Induced Hepatotoxicity and Protection
- Chemotherapy-induced organ toxicity mitigation
- Acute Lymphoblastic Leukemia research
- Arsenic contamination and mitigation
- Chemotherapy-induced cardiotoxicity and mitigation
- Saffron Plant Research Studies
- Genomics, phytochemicals, and oxidative stress
- Bioactive Compounds and Antitumor Agents
Which keywords describe Hadi Kalantar's research?
The keywords of their largest research topics: Oxidative Stress, Antioxidants, Mitochondrial Dysfunction, Chemotherapy, Apoptosis, Drug-Induced Liver Injury, Hepatotoxicity and Inflammation.
- Toxicology
- Nrf2
- Water
- Doxorubicin
- Arsenic
- Childhood Cancer
- Chemoprevention
- Nephrotoxicity
- Inflammation
- Drug-Induced Liver Injury
- Chemotherapy
- Antioxidants
- Oxidative Stress
- Mitochondrial Dysfunction
- Apoptosis
- Hepatotoxicity
- Cisplatin
- Cancer
- Acute Lymphoblastic Leukemia
- Anthracyclines
- Crocus sativus L.
- Saffron
- Keap1-Nrf2-ARE Pathway
- Quinones
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Oxidative Stress344 topics
- Antioxidants272 topics
- Mitochondrial Dysfunction272 topics
- Chemotherapy162 topics
- Apoptosis152 topics
- Drug-Induced Liver Injury151 topic
- Hepatotoxicity151 topic
- Inflammation152 topics
- Cisplatin121 topic
- Nephrotoxicity121 topic
- Cancer72 topics
- Chemoprevention72 topics
- Acute Lymphoblastic Leukemia61 topic
- Childhood Cancer61 topic
- Anthracyclines41 topic
- Arsenic41 topic
- Crocus sativus L.41 topic
- Doxorubicin41 topic
- Saffron41 topic
- Water41 topic
- Keap1-Nrf2-ARE Pathway31 topic
- Nrf231 topic
- Quinones31 topic
- Toxicology31 topic
Where does Hadi Kalantar work?
Hadi Kalantar's main affiliation in the publication record is Ahvaz Jundishapur University of Medical Sciences, Iran.
How many publications and citations does Hadi Kalantar have?
OpenAlex counts 49 works and 880 citations for Hadi Kalantar, an h-index of 17, ranking #1,403,021 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hadi Kalantar. Posts are plain text and can be reported.